Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy
Conditions
- Acute Coronary Syndrome (ACS)
- High Bleeding Risk (HBR)
- Coronary Artery Disease (CAD)
Sponsor
Shenyang Northern Hospital
Collaborators